AR088813A1 - Metodo para cuantificar el tratamiento de cancer - Google Patents
Metodo para cuantificar el tratamiento de cancerInfo
- Publication number
- AR088813A1 AR088813A1 ARP120104223A ARP120104223A AR088813A1 AR 088813 A1 AR088813 A1 AR 088813A1 AR P120104223 A ARP120104223 A AR P120104223A AR P120104223 A ARP120104223 A AR P120104223A AR 088813 A1 AR088813 A1 AR 088813A1
- Authority
- AR
- Argentina
- Prior art keywords
- bone
- scintigraphy
- cancer treatment
- bone scintigraphy
- lesions
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000007469 bone scintigraphy Methods 0.000 abstract 8
- 230000003902 lesion Effects 0.000 abstract 3
- 206010027452 Metastases to bone Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/505—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of bone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/037—Emission tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5217—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/508—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for non-human patients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Radiology & Medical Imaging (AREA)
- High Energy & Nuclear Physics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physiology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Theoretical Computer Science (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Primary Health Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nuclear Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Un método para cuantificar la respuesta al tratamiento de cáncer en pacientes con metástasis óseas utilizando una evaluación mediante gammagrafía ósea asistida por computadora que comprende: (a) obtener una imagen de gammagrafía ósea; (b) normalizar la imagen de gammagrafía ósea obtenida para identificar lesiones de gammagrafía ósea normalizadas; y (c) evaluar cuantitativamente las lesiones de gammagrafía ósea normalizadas utilizando el área de lesión de gammagrafía ósea, intensidad de gammagrafía ósea o conteo de lesión de gammagrafia ósea.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161557362P | 2011-11-08 | 2011-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR088813A1 true AR088813A1 (es) | 2014-07-10 |
Family
ID=47295170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120104223A AR088813A1 (es) | 2011-11-08 | 2012-11-08 | Metodo para cuantificar el tratamiento de cancer |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20140330170A1 (es) |
| EP (1) | EP2775921A1 (es) |
| JP (1) | JP2015505360A (es) |
| KR (1) | KR20140094597A (es) |
| CN (1) | CN104039226A (es) |
| AR (1) | AR088813A1 (es) |
| AU (1) | AU2012335750A1 (es) |
| BR (1) | BR112014011008A2 (es) |
| CA (1) | CA2854664A1 (es) |
| EA (1) | EA201490946A1 (es) |
| IL (1) | IL232493A0 (es) |
| IN (1) | IN2014CN03674A (es) |
| TW (1) | TW201323864A (es) |
| WO (1) | WO2013070903A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2758057B1 (en) | 2011-09-22 | 2017-05-31 | Exelixis, Inc. | Method for treating osteoporosis |
| US9861624B2 (en) * | 2012-05-02 | 2018-01-09 | Exelixis, Inc. | Method of treating cancer |
| US9324140B2 (en) * | 2013-08-29 | 2016-04-26 | General Electric Company | Methods and systems for evaluating bone lesions |
| CN106068255A (zh) | 2014-02-14 | 2016-11-02 | 埃克塞里艾克西斯公司 | 结晶固体形式的n‑{4‑[(6，7‑二甲氧基喹啉‑4‑基)氧基]苯基}‑n′‑(4‑氟苯基)环丙烷‑1，1‑二甲酰胺、制备方法以及使用方法 |
| CN104788372B (zh) * | 2014-07-25 | 2018-01-30 | 上海圣考医药科技有限公司 | 一种氘代卡博替尼衍生物、其制备方法、应用及其中间体 |
| JP6493884B2 (ja) * | 2016-03-09 | 2019-04-03 | 富士フイルム株式会社 | 画像表示制御装置および方法並びにプログラム |
| HUE058196T2 (hu) | 2017-05-26 | 2022-07-28 | Exelixis Inc | N-{4-[(6,7-dimetoxikinolin-4-il)oxi]fenil}-N'-(4-fluorfenil)ciklopropán-1,1-dikarboxamid kristályos szilárd sói, elõállítási eljárások és alkalmazási eljárások |
| JP6286606B1 (ja) * | 2017-09-14 | 2018-02-28 | 日本メジフィジックス株式会社 | 画像処理プログラム、画像処理装置、および画像処理方法 |
| IL300824A (en) | 2018-01-26 | 2023-04-01 | Exelixis Inc | Compounds for the treatment of kinase-dependent disorders |
| CN116808044A (zh) | 2018-06-15 | 2023-09-29 | 汉达癌症医药责任有限公司 | 激酶抑制剂的盐类及其组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US7229774B2 (en) * | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
| ES2651730T3 (es) | 2003-09-26 | 2018-01-29 | Exelixis, Inc. | Moduladores c-Met y métodos de uso |
| US20080298657A1 (en) * | 2005-11-23 | 2008-12-04 | Junji Shiraishi | Computer-Aided Method for Detection of Interval Changes in Successive Whole-Body Bone Scans and Related Computer Program Program Product and System |
| WO2008083319A1 (en) | 2006-12-29 | 2008-07-10 | Il Yang Pharmaceutical Company, Ltd. | Solid state forms of enantiopure ilaprazole |
-
2012
- 2012-11-08 BR BR112014011008A patent/BR112014011008A2/pt not_active Application Discontinuation
- 2012-11-08 JP JP2014541261A patent/JP2015505360A/ja active Pending
- 2012-11-08 CN CN201280066413.9A patent/CN104039226A/zh active Pending
- 2012-11-08 KR KR1020147015301A patent/KR20140094597A/ko not_active Application Discontinuation
- 2012-11-08 TW TW101141697A patent/TW201323864A/zh unknown
- 2012-11-08 AR ARP120104223A patent/AR088813A1/es not_active Application Discontinuation
- 2012-11-08 AU AU2012335750A patent/AU2012335750A1/en not_active Abandoned
- 2012-11-08 US US14/356,938 patent/US20140330170A1/en not_active Abandoned
- 2012-11-08 CA CA2854664A patent/CA2854664A1/en not_active Abandoned
- 2012-11-08 EA EA201490946A patent/EA201490946A1/ru unknown
- 2012-11-08 EP EP12795939.3A patent/EP2775921A1/en not_active Withdrawn
- 2012-11-08 WO PCT/US2012/064134 patent/WO2013070903A1/en active Application Filing
-
2014
- 2014-05-07 IL IL232493A patent/IL232493A0/en unknown
- 2014-05-15 IN IN3674CHN2014 patent/IN2014CN03674A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014011008A2 (pt) | 2018-06-19 |
| IL232493A0 (en) | 2014-06-30 |
| EA201490946A1 (ru) | 2014-08-29 |
| CA2854664A1 (en) | 2013-05-16 |
| JP2015505360A (ja) | 2015-02-19 |
| AU2012335750A1 (en) | 2014-06-05 |
| CN104039226A (zh) | 2014-09-10 |
| US20140330170A1 (en) | 2014-11-06 |
| EP2775921A1 (en) | 2014-09-17 |
| TW201323864A (zh) | 2013-06-16 |
| IN2014CN03674A (es) | 2015-07-03 |
| WO2013070903A1 (en) | 2013-05-16 |
| KR20140094597A (ko) | 2014-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR088813A1 (es) | Metodo para cuantificar el tratamiento de cancer | |
| CY1125068T1 (el) | Ενωσεις τετραϋποκατεστημενου αλκενιου και χρηση αυτων | |
| CY1118695T1 (el) | Αναστολεις απομεθυλασων ιστονων | |
| BR112013010015A2 (pt) | aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos | |
| ES2721635T3 (es) | Generación de imágenes de biomarcadores para el diagnóstico del dolor de espalda | |
| EP4349248A3 (en) | Apparatus for determining damaged tissue using sub-epidermal moisture measurements | |
| ATE412950T1 (de) | Quantifizierug auf basis virtueller läsionen | |
| WO2015026086A3 (ko) | 휴대가 가능한 내시경 시스템 | |
| AR080361A1 (es) | Identificacion, evaluacion y terapia de canceres con resistencia innata o adquirida a inhibidores de quinasa del linfoma anaplasico (alk) | |
| BR112015000685A2 (pt) | método para a identificação de risco clínico em um paciente possuindo ou suspeito de possuir uma infecção por influenza, método para a identificação de influenza ou pneumonia viral em um paciente, kit, método para avaliar a eficácia de um agente para o tratamento de influenza e para reduzir a severidade da doença em um indivíduo exposto a um vírus influenza. | |
| SG11201701558WA (en) | Method of detecting fibrous tissue in a biological specimen using co-localized images generated by second harmonic generation and two photon emission | |
| CY1122474T1 (el) | Μεθοδος διαγνωσης νευραλγιας του τριδυμου | |
| BR112017004883A2 (pt) | ensaio de diagnóstico baseado em fragmento de rgma | |
| BR112015027249A2 (pt) | método de diagnóstico de câncer | |
| AR092423A1 (es) | Metodo de diagnostico y tratamiento del cancer dirigido a las moleculas expresadas en celulas madre cancerosas | |
| CL2012002858A1 (es) | Combinación farmacéutica que comprende 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencilamidazol-2-il-quinolin-2-ona y al menos un inhibidor de mtor; método de tratamiento; y uso para el tratamiento y la prevención de una enfermedad proliferativa tal como cáncer de mama, tumores neuroendocrinos y linfonas, entre otras. | |
| FR2979346B1 (fr) | Nanocorps anti-vcam-1 | |
| CR11501A (es) | Tratamiento de cardiopatias usando b-bloqueantes | |
| GB2556741A (en) | Clinical thermometer | |
| BR112015009857A2 (pt) | sistema de tomografia por ablação a laser, método para tomografia por ablação a laser, sistema de análise espectroscópica e tomográfica por ablação a laser, método para análise espectroscópica e tomográfica por ablação a laser e sistema de análise espectroscópica por ablação a laser | |
| FR3004099B1 (fr) | Procede et systeme de caracterisation d'un tissu osseux. | |
| ES2485615B1 (es) | Métodos y productos para pronosticar la evolución clínica o predecir el riesgo de recidiva de una lesión papilar de mama | |
| EA201691393A1 (ru) | Методы анализа клиренса субстрата для лизосомальных ферментов | |
| FI20150314A (fi) | Menetelmä rintojen tutkimiseksi ja kasvaimien todentamiseksi kudoksessa eri taajuuksilla ilmenevien fysiologisten ilmiöiden ja muutosten perusteella, käytettäväksi yhdessä tai erikseen mammografiatutkimuksen kanssa nostamaan tutkimusten sensitiivisyyttä ja spesifisyyttä | |
| RU2013132050A (ru) | Способ прогнозирования краевых некрозов в области послеоперационной раны или остеосинтезе переломов костей голени |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |